Microsoft continues to be Wall Street’s software sweetheart, with Legacy Capital Wealth Partners LLC upping their stake by ...

Values Added Financial LLC increased its Apple stake by 6.5%, now holding 28,275 shares worth over $7 million. Apple is the ...

Renaissance Technologies dramatically ramped up its stake in Southern Copper by over 1,400% in Q4, acquiring nearly 408,000 ...

NVIDIA’s rollercoaster continues as Rosenblatt Securities slashes its target price from $220 to $200, despite keeping a “buy” ...

Alphabet just received another vote of confidence as Needham & Company reiterated its “buy” rating with a price target of ...

CreativeOne Wealth LLC dramatically boosted its Meta stake by 44.4% in the fourth quarter, now holding $17.6 million worth of ...

Van Hulzen Asset Management increased its Amazon stake by 1%, snagging 89,378 shares now worth nearly $19.6 million. Amazon.com is now Van Hulzen’s 19th largest holding, making up 1.4% of its ...

Redburn Atlantic trimmed Visa’s price target from $310 to $300 but kept a Neutral rating, proving that sometimes, even ...

Chevron’s stock tiptoed up 0.8%, but before you celebrate with caviar, trading volume dropped a dramatic 70%—someone hit ...

Zacks Research just trimmed its FY2025 earnings forecast for AbbVie, shaving it from $12.14 to $12.02 per share. This modest ...

Barclays lowered Wells Fargo’s price target from $92.00 to $87.00, though it maintained an “overweight” rating, suggesting ...

Eli Lilly’s new weight-loss pill, orforglipron, is stirring excitement after outperforming Ozempic in early trials. The drug's trial results triggered a 14% stock surge and a storm of bullish analyst ...